Workflow
美年健康(002044):AI赋能持续深化,健康管理场景进一步拓展

Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - The company reported a revenue of 4.109 billion yuan in the first half of 2025, a year-on-year decrease of 2.28%, with a net profit attributable to the parent company of -221 million yuan, down 2.59% year-on-year [1] - The company is focusing on both individual and group health check services, achieving a total of 9.55 million visits, with group check services contributing 67% to revenue [2] - AI-driven products have shown significant growth, with revenue from AI-related products reaching 140 million yuan, a year-on-year increase of 62.36% [2] - The company has expanded its network to 566 branches, including 304 controlled health check branches, maintaining a leading position in the industry [2] - Cost control measures have begun to show results, with sales expenses decreasing by 8.75% year-on-year in the first half of 2025 [3] Financial Performance - The company expects revenues of 10.599 billion yuan, 11.498 billion yuan, and 12.800 billion yuan for 2025, 2026, and 2027 respectively, with year-on-year growth rates of -1.0%, +8.5%, and +11.3% [4] - The net profit attributable to the parent company is projected to be 385 million yuan, 731 million yuan, and 950 million yuan for the same years, reflecting growth rates of +36.4%, +89.8%, and +30.1% [4] - The latest diluted EPS is expected to be 0.10 yuan, 0.19 yuan, and 0.24 yuan for 2025, 2026, and 2027 respectively [5] Market Position - The company has a total market capitalization of approximately 20 billion yuan, with a closing price of 5.11 yuan as of September 19, 2025 [6] - The company operates in the healthcare service industry, focusing on health management and AI integration to enhance operational efficiency [4][6]